Not sure if you replied to the right message, but yeah there are safety risks that's why we evaluate them in trials. Favipiravir also has pretty bad side effects (teratogenic effects -thalidomide like). That's why we run these trials, and using already approved drugs or more widely developed drugs will mean we're dealing with known evils as opposed to unknown evils